---
layout: post
title: 'USAN Watch: July 2013'
date: '2013-07-02T20:59:00.002+01:00'
author: John Overington
tags:
- INNS and USANS
modified_time: '2013-07-03T15:39:02.376+01:00'
thumbnail: http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-4716866377212836838
blogger_orig_url: http://chembl.blogspot.com/2013/07/usan-watch-july-2013.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png"><img border="0" src="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png" /></a></div>
<span class="Apple-style-span" style="font-family: inherit;">The USANs for July 2013 have recently been published.</span><br />
<span class="Apple-style-span" style="font-family: inherit;"><br /></span>
<br />
<table border="1"><tbody>
<tr><td><b><span class="Apple-style-span" style="font-family: inherit;">USAN </span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Research Code </span></b></td><td><b>InChIKey (Parent)</b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Drug Class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Therapeutic class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Target</span></b></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/formofilcon-b.pdf">formofilcon B</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<br /></div>
</div>
</div>
</td><td><span style="background-color: white; line-height: 17px; text-align: left;"><span style="font-family: inherit;">n/a</span></span></td><td>contact lens polymer</td><td>polymer&nbsp;</td><td>n/a</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/futuximab.pdf">futuximab</a></td><td>992DS, Sym004</td><td>n/a</td><td>therapeutic</td><td>monoclonal antibody</td><td>EGFR</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/muparfostat.pdf">muparfostat</a>, <a href="http://www.ama-assn.org/resources/doc/usan/muparfostat.pdf">muparfostat sodium</a></td><td>PI-88</td><td>n/a</td><td>therapeutic</td><td>oligosaccharide</td><td>VEGF, FGF-1, FGF-2</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/omafilcon-b.pdf">omafilcon B</a></td><td><br />
<div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<br /></div>
</div>
</div>
</td><td><span style="color: #121212;"><span style="line-height: 20px;">n/a</span></span></td><td>contact lens polymer</td><td>polymer</td><td>n/a</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/stenfilcon-a.pdf">stenfilcon A</a></td><td><div class="page" title="Page 2">
<div class="layoutArea">
<div class="column">
</div>
</div>
</div>
</td><td>n/a</td><td>contact lens polymer</td><td>polymer</td><td>n/a</td></tr>
</tbody></table>
